Cargando…
Ampicillin Silver Nanoformulations against Multidrug resistant bacteria
The present study reported a single step synthesis of silver nanoparticles using ampicillin (Amp-AgNps), a second-generation β lactam antibiotic to get nanoformulation having dual properties that of antibiotic and silver. The Amp-AgNps was characterized by UV-VIS spectroscopy, TEM, XRD, FTIR and TGA...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6497658/ https://www.ncbi.nlm.nih.gov/pubmed/31048721 http://dx.doi.org/10.1038/s41598-019-43309-0 |
_version_ | 1783415503470985216 |
---|---|
author | Khatoon, Nafeesa Alam, Hammad Khan, Afreen Raza, Khalid Sardar, Meryam |
author_facet | Khatoon, Nafeesa Alam, Hammad Khan, Afreen Raza, Khalid Sardar, Meryam |
author_sort | Khatoon, Nafeesa |
collection | PubMed |
description | The present study reported a single step synthesis of silver nanoparticles using ampicillin (Amp-AgNps), a second-generation β lactam antibiotic to get nanoformulation having dual properties that of antibiotic and silver. The Amp-AgNps was characterized by UV-VIS spectroscopy, TEM, XRD, FTIR and TGA. FTIR and TGA results suggested that amine group of Ampicllin reduce the metalic silver into nano form. These results were further validated by computational molecular dynamics simulation. The antibacterial potential of Amp-AgNps was investigated against sensitive and drug resistant bacteria. MIC of Amp-AgNps against 6 different bacterial strains were in the range of 3–28 µg/ml which is much lower than the MIC of ampicillin (12–720 µg/ml) and chemically synthesized silver nanoparticles (280–640 µg/ml). The repeated exposure to drugs may lead to development of resistance mechanism in bacteria against that drug, so the efficacy of Amp-AgNps after repeated exposure to bacterial strains were also studied. The results indicate that bacterial strains do not show any resistance to these Amp-AgNps even after exposure up to 15 successive cycles. The biocompatibility of these Amp-AgNps was checked against cell lines by using Keratinocytes cell lines (HaCaT). |
format | Online Article Text |
id | pubmed-6497658 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-64976582019-05-17 Ampicillin Silver Nanoformulations against Multidrug resistant bacteria Khatoon, Nafeesa Alam, Hammad Khan, Afreen Raza, Khalid Sardar, Meryam Sci Rep Article The present study reported a single step synthesis of silver nanoparticles using ampicillin (Amp-AgNps), a second-generation β lactam antibiotic to get nanoformulation having dual properties that of antibiotic and silver. The Amp-AgNps was characterized by UV-VIS spectroscopy, TEM, XRD, FTIR and TGA. FTIR and TGA results suggested that amine group of Ampicllin reduce the metalic silver into nano form. These results were further validated by computational molecular dynamics simulation. The antibacterial potential of Amp-AgNps was investigated against sensitive and drug resistant bacteria. MIC of Amp-AgNps against 6 different bacterial strains were in the range of 3–28 µg/ml which is much lower than the MIC of ampicillin (12–720 µg/ml) and chemically synthesized silver nanoparticles (280–640 µg/ml). The repeated exposure to drugs may lead to development of resistance mechanism in bacteria against that drug, so the efficacy of Amp-AgNps after repeated exposure to bacterial strains were also studied. The results indicate that bacterial strains do not show any resistance to these Amp-AgNps even after exposure up to 15 successive cycles. The biocompatibility of these Amp-AgNps was checked against cell lines by using Keratinocytes cell lines (HaCaT). Nature Publishing Group UK 2019-05-02 /pmc/articles/PMC6497658/ /pubmed/31048721 http://dx.doi.org/10.1038/s41598-019-43309-0 Text en © The Author(s) 2019 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Article Khatoon, Nafeesa Alam, Hammad Khan, Afreen Raza, Khalid Sardar, Meryam Ampicillin Silver Nanoformulations against Multidrug resistant bacteria |
title | Ampicillin Silver Nanoformulations against Multidrug resistant bacteria |
title_full | Ampicillin Silver Nanoformulations against Multidrug resistant bacteria |
title_fullStr | Ampicillin Silver Nanoformulations against Multidrug resistant bacteria |
title_full_unstemmed | Ampicillin Silver Nanoformulations against Multidrug resistant bacteria |
title_short | Ampicillin Silver Nanoformulations against Multidrug resistant bacteria |
title_sort | ampicillin silver nanoformulations against multidrug resistant bacteria |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6497658/ https://www.ncbi.nlm.nih.gov/pubmed/31048721 http://dx.doi.org/10.1038/s41598-019-43309-0 |
work_keys_str_mv | AT khatoonnafeesa ampicillinsilvernanoformulationsagainstmultidrugresistantbacteria AT alamhammad ampicillinsilvernanoformulationsagainstmultidrugresistantbacteria AT khanafreen ampicillinsilvernanoformulationsagainstmultidrugresistantbacteria AT razakhalid ampicillinsilvernanoformulationsagainstmultidrugresistantbacteria AT sardarmeryam ampicillinsilvernanoformulationsagainstmultidrugresistantbacteria |